Papers
3
Total Citations
103
H-Index
3
About
Dr. Lei Hou is a pioneering surgeon whose work has redefined the landscape of minimally invasive oncologic surgery, particularly in the treatment of thyroid and breast cancers. His primary research focuses on advancing robotic surgical techniques to improve patient outcomes, with a special emphasis on the bilateral axillo-breast approach (BABA). Dr. Hou’s landmark 2016 study, which compared robotic total thyroidectomy with central lymph node dissection to conventional open surgery for papillary thyroid microcarcinoma (64 citations), demonstrated that the robotic approach offers superior cosmetic results and faster recovery without compromising oncologic safety—a critical finding for the predominantly young female patient population. He further solidified his expertise with a large-scale 2019 study on robotic lateral cervical lymph node dissection (34 citations), showcasing its feasibility and safety in 260 patients. More recently, Dr. Hou has innovated in breast cancer care by developing a robot-assisted technique for internal mammary lymph node chain dissection, addressing a previously challenging anatomical area. With over 100 cumulative citations, his work has established new standards for minimally invasive cancer surgery, directly improving quality of life for thousands of patients while maintaining rigorous oncologic principles.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3